The role of serum bile acid profile in differentiation between nonalcoholic fatty liver disease and chronic viral hepatitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-6226
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The role of serum bile acid profile in differentiation between nonalcoholic fatty liver disease and chronic viral hepatitis ; volume:10 ; number:1 ; day:4 ; month:11 ; year:2020 ; pages:1-10 ; date:12.2020
Egyptian liver journal ; 10, Heft 1 (4.11.2020), 1-10, 12.2020
- Urheber
-
Elsheashaey, Azza
Obada, Manar
Abdelsameea, Eman
Bayomy, Mohamed F. F.
El-Said, Hala
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43066-020-00057-5
- URN
-
urn:nbn:de:101:1-2020121720124602297701
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Elsheashaey, Azza
- Obada, Manar
- Abdelsameea, Eman
- Bayomy, Mohamed F. F.
- El-Said, Hala
- SpringerLink (Online service)
Ähnliche Objekte (12)
The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma
Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease
Viral hepatitis
Non-alcoholic fatty liver disease
Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Artificial intelligence in nonalcoholic fatty liver disease
The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma
Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease
Viral hepatitis
Non-alcoholic fatty liver disease
Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Artificial intelligence in nonalcoholic fatty liver disease
The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma
Exploring serum bile acids as potential noninvasive biomarkers for nonalcoholic fatty liver disease
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease
Viral hepatitis
Non-alcoholic fatty liver disease
Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity